Sermorelin and GHRP-6 are peptides that stimulate the release of growth hormone. Sermorelin is currently used in a clinical setting to evaluate growth hormone secretion, while GHRP-6 is being studied for its potential ability to improve bone density, diminish scaring, combat effects of dementia, and reduce seizure activity.
GHRP-2 is a synthetic peptide which mimics ghrelin, the gut peptide which binds to the growth hormone (GH) secretagogue receptor and stimulates GH secretion and appetite/meal initiation. GHRP-6 is a synthetic hexapeptide which specifically stimulates secretion of growth hormone (GH) by pituitary somatotrophs. Sermorelin is a growth-hormone-releasing hormone analogue currently used in a clinical setting to evaluate growth hormone secretion.
Sermorelin is a growth hormone-releasing hormone analogue used to evaluate growth hormone secretion. It is of interest to researchers for its potential ability to improve bone density, diminish scaring, combat effects of dementia, and reduce seizure activity. GHRP-2 is a synthetic peptide which binds to the growth hormone secretagogue receptor and has been extensively studied for its ability to stimulate growth hormone secretion.